| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.16(B) |
| Last
Volume: |
762,316 |
Avg
Vol: |
474,459 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
3 |
6 |
6 |
8 |
| Total Sell Transactions |
5 |
11 |
16 |
28 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2022-01-28 |
4 |
D |
$312.24 |
$1,210,554 |
D/D |
(3,877) |
34,223 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,029 |
38,100 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2022-01-28 |
4 |
D |
$312.24 |
$1,674,855 |
D/D |
(5,364) |
21,382 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,321 |
26,746 |
|
- |
|
| Mackay Martin |
Director |
• • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
63 |
9,662 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2021-12-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,771 |
15,051 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2021-12-01 |
4 |
GD |
$0.00 |
$0 |
I/I |
400 |
11,912 |
|
- |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2021-11-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
182 |
8,280 |
|
- |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-10-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
14,813 |
0 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2021-09-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
531 |
27,071 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-09-14 |
4 |
AS |
$439.90 |
$1,031,126 |
D/D |
(2,344) |
27,602 |
|
-27% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-09-13 |
4 |
AS |
$441.66 |
$35,817 |
D/D |
(81) |
29,946 |
|
-23% |
|
| Massaro George |
Director |
• • – |
2021-08-31 |
4 |
S |
$442.16 |
$1,123,457 |
D/D |
(2,539) |
4,855 |
|
19% |
|
| Massaro George |
Director |
• • – |
2021-08-31 |
4 |
OE |
$164.24 |
$417,005 |
D/D |
2,539 |
7,394 |
|
- |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2021-08-16 |
4 |
S |
$415.24 |
$2,872,236 |
D/D |
(6,917) |
6,386 |
|
10% |
|
| Creamer Victoria L |
EVP & Chief People Officer |
• • – |
2021-08-16 |
4 |
OE |
$124.13 |
$1,005,330 |
D/D |
6,917 |
13,303 |
|
- |
|
| Massaro George |
Director |
• • – |
2021-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
4,855 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-08-09 |
4 |
S |
$406.36 |
$712,954 |
D/D |
(1,750) |
14,425 |
|
12% |
|
| Laplume Joseph W |
EVP, Corp Strategy & Develop |
• • – |
2021-08-06 |
4 |
S |
$400.91 |
$1,488,175 |
D/D |
(3,700) |
8,462 |
|
11% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-08-06 |
4 |
S |
$400.89 |
$4,017,867 |
D/D |
(10,000) |
202,299 |
|
11% |
|
| Foster James C |
Chairman, President and CEO |
• • – |
2021-08-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
212,299 |
|
- |
|
| Kochevar Deborah Turner |
Director |
• • – |
2021-08-06 |
4 |
S |
$405.73 |
$1,433,071 |
D/D |
(3,526) |
6,096 |
|
11% |
|
| Kochevar Deborah Turner |
Director |
• • – |
2021-08-06 |
4 |
OE |
$164.24 |
$417,005 |
D/D |
2,539 |
9,622 |
|
- |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2021-08-06 |
4 |
S |
$400.83 |
$4,989,752 |
D/D |
(12,387) |
4,371 |
|
11% |
|
| Barbo William D |
Corporate Executive VP & CCO |
• • – |
2021-08-06 |
4 |
OE |
$109.34 |
$1,020,717 |
D/D |
7,472 |
16,758 |
|
- |
|
1166 Records found
|
|
Page 10 of 47 |
|
|
1.28 (0.61%) 
